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The aim of this study, was to characterize the extended-spectrum-β-lactamases (ESBLs)
producing clinical strains of Escherichia coli isolated between January 2009 and June
2012 from Algerian hospitals and to determine the prevalence of 16S rRNA methylase
among them. Sixty-seven ESBL-producers were detected among the 239 isolates
included: 52 CTX-M-15-producers, 5 CTX-M-3-producers, 5 CTX-M-1-producers, 2
CTX-M-14-producers, 2 SHV-12-producers and one TEM-167-producer. Among the
ESBL–producing strains twelve harbored 16S rRNA methylase genes: 8 rmtB and 4
armA. rmtB was located on a IncFIA plasmid and armA was located either on a IncL/M
or a IncFIA plasmid. RmtB-producing isolates were genotypically related and belonged
to the sequence type ST 405 whereas ArmA-producing isolates belonged to ST10,
ST 167, and ST 117. This first description of 16S rRNA methylases among E. coli in
Algerian hospitals pointed out the necessity to establish control measures to avoid their
dissemination.
Keywords: Escherichia coli, extended-spectrum β-lactamase, 16S rRNA methylase, armA, rmtB, Algeria
INTRODUCTION
The emergence of β-lactam resistance in Escherichia coli which is the most common cause of
Gram-negative infections has become a significant health concern, mainly due to the production
of extended-spectrum beta-lactamases (ESBLs) (Pitout and Laupland, 2008). Indeed, CTX-M
ESBLs (more than 150 enzymes) have increased significantly in Enterobacteriaceae, particularly
Frontiers in Microbiology | www.frontiersin.org 1 September 2016 | Volume 7 | Article 1409
fmicb-07-01409 September 8, 2016 Time: 12:29 # 2
Ayad et al. CTX-M, ArmA, and RmtB in E. coli from Algeria
in E. coli, in most regions of the world (Cantón and Coque,
2006). Another worrisome feature is the emergence of isolates
resistant to all clinically important aminoglycosides related to
the production of 16S rRNA methylases. In 2003, the first 16S
rRNA methylase gene, armA, was identified (Galimand et al.,
2003). To date eleven 16S rRNA methylases genes (rmtA, rmtB,
rmtC, rmtD, rmtD2, rmtE, rmtF, rmtG, rmtH, armA, and npmA)
have been identified, armA and rmtB being the most frequently
described in Enterobacteriaceae (Galimand et al., 2003; Bogaerts
et al., 2007; Yamane et al., 2007; Fritsche et al., 2008). As these
genes are usually located on plasmids they can easily transfer to
other bacteria (Nagasawa et al., 2014).
In Algeria, the first CTX-M enzymes have been reported in
2005 in clinical strains of Salmonella enterica from Constantine,
East of Algeria (Naas et al., 2005). Since then, several surveys
in the north of Algeria have reported the presence of CTX-M-
type enzyme and associated resistance to non-β-lactam markers
in various species of Enterobacteriaceae (Baba Ahmed-Kazi Tani
and Arlet, 2014). Concerning 16S rRNA methylases only ArmA
has been detected to date. It was identified for the first time
in Enterobacteriaceae strains isolated from an Algerian patient
transferred to Belgium (Bogaerts et al., 2007). It was subsequently
identified in clinical isolates of S. enterica in Constantine
associated with CTX-M-3 or CTX-M-15 (Naas et al., 2009,
2011) and in clinical strains of Salmonella non-Typhi in Annaba
associated with CTX-M-15 and CMY-2 (Bouzidi et al., 2011).
Recently, it was also described in clinical isolates of Klebsiella
pneumoniae, Acinetobacter baumannii, Enterobacter cloacae, and
Serratia marcescens (Bakour et al., 2014; Belbel et al., 2014; Batah
et al., 2015; Khennouchi et al., 2015).
In this study, we have characterized the ESBL-producing
clinical strains of E. coli isolated between October 2008 and June
2012 in three hospitals in Western Algeria and determined the
prevalence of 16S rRNA methylase genes among them.
MATERIALS AND METHODS
Bacterial Strains
Two hundred and thirty-nine isolates of E. coli collected between
October 2008 and June 2012 from three different hospitals
located in North-Western Algeria (Tlemcen, Sidi Bel Abbes and
Oran) were included. Two hundred and thirty-seven strains
were isolated from patients admitted to the intensive care
unit (ICU), surgery and neurosurgery wards. Two isolates have
been recovered from hospital environment. Identification was
performed using the API 20E system (BioMerieux) and/or
matrix-assisted laser desorption/ionization time-of-flight mass
spectrometry (MALDI-TOF MS).
Antibiotic Susceptibility Testing
Twenty three antibiotics (Bio-Rad) were tested (Table 1).
Antibiotic susceptibility testing was determined by disk diffusion
method and the minimum inhibitory concentration (MICs) of
colistin was determined by a dilution method in Mueller-Hinton
(MH) broth (Bio-Rad) as described by the European Committee
on Antimicrobial Susceptibility Testing1. Detection of ESBL
production was performed by double disk synergy test (Jarlier
et al., 1988).
Bacterial DNA Preparation, Gene
Amplification, and Sequencing
Bacterial DNA preparation, gene amplification, sequencing, and
nucleotide sequence analysis were performed as previously
described (Siebor and Neuwirth, 2011). The primers used for
the PCRs are listed in Table 2. All the isolates were analyzed
for the presence of blaCTX−M, blaTEM, and blaSHV. The resistant
strains to all aminoglycosides tested were further analyzed for the
presence of armA and rmtB.
Genotyping of the Isolates Producing
16S rRNA Methylase
The strains were submitted to genotypic analysis by Pulsed-
Field Gel Electrophoresis (PFGE) and Multilocus sequence typing
(MLST). PFGE was performed following DNA digestion by XbaI
as already described (Neuwirth et al., 1996). Restriction patterns
were interpreted according to Tenover’s criteria (Tenover et al.,
1995), and the isolates have been classified into different
pulsotypes. Pulsotypes were compared by calculation of the
Dice correlation coefficient with DendroUPGMA software2 and
were clustered into a dendrogram by UPGMA. Strains were
defined as having a clonal relationship at a criterium of 85%
similarity (Ejrnaes et al., 2006). MLST was performed using seven
conserved housekeeping genes of E. coli (adk, fumC, gyrB, icd,
mdh, purA, and recA) as previously described (Wirth et al., 2006).
The sequences types were determined by referring to the open-
source software freely available at MLST Databases at the ERI,
University College Cork website3.
Mating Experiments and Plasmids
Analysis
Mating experiments to attempt to transfer resistance genes
were carried out using rifampicin resistant E. coli K-12
C600 recipient strain as described previously (Chen et al.,
2007). Transconjugants were selected on Drigalski agar plates
containing amikacin (4 mg/L), gentamicin (4 mg/L), and
rifampicin (200 mg/L), on Drigalski agar plates containing
cefotaxime (4 mg/L) and rifampicin (200 mg/L), on Drigalski agar
plates containing gentamicin (4 mg/L) and rifampicin (200 mg/L)
and on Drigalski agar plates containing amikacin (30 mg/L) and
rifampicin (200 mg/L).
Identification of plasmids by PCR-based replicon typing
was performed on the donor strains and their transconjugants
as described previously (Carattoli et al., 2005). Plasmid sizes
were determined by digestion of whole-genome DNA with
S1 endonuclease to linearize the plasmids and PFGE to
separate them. Plasmids obtained were transferred to nylon
membranes and hybridized with digoxigenin-labeled specific
1www.eucast.org
2http://genomes.urv.cat/UPGMA/
3http://mlst.ucc.ie/mlst/dbs/Ecoli
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TABLE 1 | Antimicrobial resistance of extended-spectrum-β-lactamases
producing Escherichia coli isolated from three hospitals in Algeria.
Antimicrobial agents Resistance rate (%)
Tlemcen Sidi Bel Abbes Oran Total
(n = 35) (n = 13) (n = 19) (n = 67)
Amoxicillin 100 100 100 100
Amoxicillin–clavulanic
acid
82.8 92.3 42.1 73.1
Ticarcillin 100 100 100 100
Ticarcillin–clavulanic
acid
97.1 100 89.5 95.5
Piperacillin 100 100 100 100
Piperacillin–tazobactam 40 15.4 0 23.9
Ertapenem 0 0 0 0
Imipenem 0 0 0 0
Cefoxitin 40 38.5 26.3 35.8
Cefotaxime 100 100 94.7 98.5
Ceftazidime 91.4 92.3 84.2 89.5
Cefepime 100 92.3 89.5 95.5
Aztreonam 100 100 100 100
Kanamicin 60 46.1 57.9 56.7
Gentamicin 77.1 76.9 63.2 73.1
Tobramycin 77.1 76.9 63.2 73.1
Amikacin 25.71 7.7 15.8 19.4
Netilmicin 48.6 61.5 57.9 53.7
Nalidixic acid 68.6 53.8 89.5 71.6
Ofloxacin 68.6 61.5 89.5 73.1
Ciprofloxacin 68.6 61.5 84.2 71.6
Colistin 0 0 0 0
Trimethoprim–
Sulfamethoxazole
80 84.6 57.9 74.6
probes [blaCTX−M group 1, blaTEM, armA, rmtB, and replicon
groups (IncL/M, IncFIA, IncFIB, and IncN)] (Barton et al., 1995).
RESULTS
ESBL Producers
Sixty-seven ESBL-producing isolates have been detected: 35 from
Tlemcen hospital, 13 from Sidi Bel Abbes hospital and 19
from Oran hospital. Isolates were mainly recovered from ICU
(58.2%), followed by 26.9% from surgery department. Eighteen
strains (26.9%) were recovered from wound pus, 17 (25.4%)
from tracheal aspirate, 17 (25.4%) from urine and urinary
catheters, 7 (10.4%) from rectal swabs, 4 (6%) from bedsores,
1 (1.5%) from catheter, 1 (1.5%) from gastric tube, and 2 (3%)
from hospital environment. Among these strains 64 isolates
(95.5%) carried blaCTX−M (52 blaCTX−M−15, 5 blaCTX−M−3, 5
blaCTX−M−1, 2 blaCTX−M−14), while 2 carried blaSHV−12 and 1
blaTEM−167.
All the ESBL-producing isolates remained susceptible
to imipenem, ertapenem, and colistin and most of them
to piperacillin-tazobactam (76%), cefoxitin (64.2%),
TABLE 2 | Primers used for PCRs.
Amplified DNA Primer Oligonucleotide sequence (5′–3′)
TEM–F1 ATAAAATTCTTGAAGACGAAA
blaTEM TEM–F CTTATTCCCTTTTTTGCGGC
TEM–R GGTCTGACAGTTACCAATGC
blaSHV SHV–F GGGTTATTCTTATTTGTCGC
SHV–R GTTAGCGTTGCCAGTGCTCG
blaCTX−M CTX-M–F ATGTGCAGYACCAGTAA
CTX-M–R ACCGCRATATCRTTGGT
blaCTX−M group 1 CTX-M-gr1–F TCGTCTCTTCCAGA
CTX-M-gr1–R CCGTTTCCGCTATTA
blaCTX−M group 9 CTX-M-gr9–F ATGGTGACAAAGAGAGTGCA
CTX-M-gr9–R ACAGCCCTTCGGCGATGATT
armA armA-F GTGCGAAAACAGTCGTAG
armA-R GAAGTCAGGATACACCAG
rmtB rmtB-F GAGACACCGATGAACATC
rmtB-R CCTTCTGATTGGCTTATC
and amikacin (80.6%). However most of the strains
were resistant to all other antibiotics tested (>53%)
(Table 1).
Characterization of 16S rRNA
Methylase-Producers (Table 3;
Supplementary Figure S1)
Twelve isolates were resistant to all aminoglycosides tested of
which four strains harbored armA and 8 rmtB. ArmA was
detected among CTX-M-15, CTX-M-1, and TEM-167-producers
whereas rmtB was detected only among CTX-M-15-producers
(Table 3). The eight RmtB-producing strains all originated from
Tlemcen hospital belonged to pulsotype A and to ST 405. A wider
diversity was observed among the four ArmA-producers that
belonged to three different pulsotypes (B, C, and D) and three
different ST: ST10 (one isolate from Sidi Bel Abbes hospital),
ST167 (one from Tlemcen hospital), and ST117 (two isolates
from Oran hospital).
In the eight isolates, rmtB was located on a IncFIA plasmid.
In four cases blaCTX−M−15 was located on the same plasmid
while it was located on a IncI1 plasmid in the other four
cases. IncFIA was transferred only in the presence of IncI1.
armA was located either on a transferable IncL/M plasmid
(with blaCTX−M−15) or on a IncFIA plasmid (in these two
cases blaCTX−M−1 or blaTEM−167 were located on a IncN
plasmid).
DISCUSSION
Our results are in accord with previous studies and confirm
that CTX-M-15 is the predominant ESBL encountered among
E. coli in Algerian hospitals (Ramdani-Bouguessa et al., 2006;
Baba Ahmed-Kazi Tani et al., 2013). The same situation
is also observed in Tunisia (Mamlouk et al., 2006) and
Morocco (Girlich et al., 2014) illustrating the large spread of
CTX-M-15-producing E. coli in the north African countries.
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Nevertheless, the CTX-M-1, CTX-M-14, SHV-12, and TEM-
167 ESBLs also detected in our study had never been reported
to date among E. coli strains in Algeria. There is a single
description of CTX-M-14-producing S. enterica collected from
Draa-El-Mizan hospital, east of Algeria (Iabadene et al., 2009)
whereas SHV-12 has already been detected in clinical isolates
of K. pneumoniae and E. cloacae in Algeria (Baba Ahmed-
Kazi Tani and Arlet, 2014). There is no description of
TEM-167 to date, only blaTEM−167 is available in GenBank
(FJ360884).
Our study further highlights the emergence of 16S rRNA
methylase enzymes among ESBL-producing E. coli strains in
the west of Algeria. Among our collection, the prevalence
rate of 16S rRNA methylase determinants was 18%, which
is very high compared to those reported in Japan (0.03%)
(Yamane et al., 2007), in Turkey (0.7%) (Bercot et al., 2010), in
France (1.3%) (Bercot et al., 2008), and in China (10%) (Wu
et al., 2009). The detection of RmtB-producing E. coli is an
interesting finding of our study. Indeed the RmtB enzyme has
never been reported in Algeria. The eight isolates producing
RmtB were genotypically related and belonged to ST405.
Interestingly ST405 associated or not with production of CTX-
M-15 ESBL is increasingly reported worldwide and belongs to
the high-risk clones in the dissemination of antibiotic resistance
(Woodford et al., 2011). The association of blaCTX−M−15 and
rmtB on a conjugative plasmid (also carrying the plasmid-
mediated fluoroquinolone eﬄux pump gene qepA) in one ST405
E. coli isolate has been reported in the United States (Tian
et al., 2011) but the plasmid was not typed by PCR-based
replicon.
All RmtB-producers have been recovered in Tlemcen Hospital
and seven of them were collected in ICU suggesting patient cross
contamination in this ward.
Therefore there is a need to reinforce the compliance of
health-care workers with the infection control measures. The
epidemiological results concerning ArmA-producers is quite
different: the four isolates recovered in three hospitals in Western
Algeria belonged to three different pulsotypes suggesting
horizontal spread of the resistance determinants among E. coli.
There are several reports of ArmA-producers among different
species of Enterobacteriaceae and also A. baumannii from
Algerian Hospitals (Bogaerts et al., 2007; Naas et al., 2009,
2011; Bouzidi et al., 2011; Bakour et al., 2014; Belbel et al.,
2014; Batah et al., 2015; Khennouchi et al., 2015). The
production of 16S rRNA methylase together with the production
of ESBL observed in our study (RmtB plus CTX-M-15 or
ArmA plus CTX-M-15) corresponds to an emerging and
threatening combination reported worldwide (Bogaerts et al.,
2007; Khennouchi et al., 2015). To our best knowledge two
combinations detected in our study were not reported before:
ArmA plus CTX-M-1 and ArmA plus TEM-167 in two isolates
clonally related (OE11 and OE13) recovered simultaneously from
Oran’s hospital.
Our data indicated that the diversity of ESBL among E. coli
is growing in Algerian hospitals (CTX-M-1, CTX-M-14, CTX-
M-15, TEM-167, and SHV-12) and that new mechanisms
are emerging (16S rRNA methylases). In our study 11 out
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of 12 isolates that co-produced ESBL and methylase were
resistant to all antibiotics tested except carbapenems and colistin,
making of them the only available therapeutic option for
these strains. Therefore the public health impact is potentially
important.
CONCLUSION
There is a need for implementation of antimicrobial stewardship
programs in Algerian hospitals to make the best use of the
available antibiotics and to avoid as much as possible the
unreasonable use of broad-spectrum molecules leading to the
emergence of resistant isolates. Also strict control measures have
to be elaborated to avoid the spread of multiresistant organisms
such as those described here that co-produced ESBL and 16S
rRNA methylase.
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